- 2
- 1
- 1
- 1
- 1
FA
Franck André
6
Documents
Identifiants chercheurs
franck-m-andre-
0000-0001-6297-1433
- IdRef : 120415488
Présentation
Publications
- 3
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 6
- 6
- 5
- 5
- 5
- 4
- 4
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 1
- 1
- 2
|
|
Cell Electropermeabilisation Enhancement by Non-Thermal-Plasma-Treated PBSCancers, 2020, 12 (1), pp.219. ⟨10.3390/cancers12010219⟩
Article dans une revue
hal-02448072v1
|
Anticancerous plasma-electro-chemotherapy: first in-vivo studiesTherapeutic ROS and Immunity in Cancer—The TRIC-21, ZIK plasmatis; ONKOTHER-H, Jul 2021, Greifswald, Germany. pp.16
Communication dans un congrès
hal-03364441v1
|
|
Unaccounted bias in plasma in vitro experiments and the translation to in vivo: key issues and challenges8th International Conference on Plasma Medicine (ICPM8), International Society of Plasma Medicine, Kwangwoon University, Aug 2021, Incheon, South Korea
Communication dans un congrès
hal-03351810v1
|
|
Cell Electropermeabilization Enhancement by Non-Thermal Plasma-Treated LiquidJournées du GDR HAPPYBio, GDR HAPPYBio, Nov 2019, Nouan Le Fuzelier, France
Communication dans un congrès
hal-02413786v1
|
|
Characterization of Atmospheric Pressure Multijet Plasma Source Effects on Mouse SkinICPM7, ISPM, Jun 2018, Philadelphia, United States
Communication dans un congrès
hal-01942998v1
|
|
To Ground or not to Ground: a key question during plasma treatmentsJournées du GDR HAPPYBio, GDR HAPPYBio, Nov 2018, La Rochelle, France
Communication dans un congrès
hal-01946034v1
|